Stephen D. Cassivi, M.D., M.S.
Dr. Stephen D. Cassivi is a thoracic surgeon and researcher at the Mayo Clinic in Rochester, Minnesota. He specializes in minimally invasive surgical techniques to treat lung cancer, esophageal cancer, and other thoracic malignancies.[1] Dr. Cassivi’s skills include robotic surgery and video-assisted thoracic surgery, and his focus is on the delivery of brachytherapy as a supplement to the surgical treatment of malignancies. He is also working with colleagues on tissue engineering and stem-cell-based options for replacing segments of the esophagus.[2]
Education and Career
Dr. Cassivi began his educational journey with baccalaureate studies at the Lycee Charles de Foucault in Paris. He studied Political Science & Biology as an undergraduate at the University of Ottawa in Canada and followed with a Doctorate in Medicine, graduating Magna cum Laude, from the University of Ottawa Faculty of Medicine. He earned a Master of Science from the University of Toronto’s Institute of Medical Science and completed a residency in General Surgery from the same institution. He also completed a residency in Cardiothoracic Surgery at Barnes Jewish Hospital of the Washington University of St. Louis, Missouri.[1]
In addition to his role as a clinical practitioner and researcher at Mayo Clinic in Rochester, Minnesota, Dr. Cassivi served as Medical Director and member of the Executive Committee for Mayo Clinic Healthcare’s partnership with Oxford University Clinic in London.
Professional Memberships and Activities
Dr. Cassivi is an active member of many medical organizations and societies and plays an important role on numerous committees. His professional activities include:[1]
- Editorial Board Member, Video-Assisted Thoracic Surgery (VATS)
- European Society of Thoracic Surgeons
- Abstract Reviewer, Society of Thoracic Surgeons
- Royal Society of Medicine
- Fellow, Royal College of Surgeons of England
- Abstract Reviewer, Annual Meeting of the European Society of Thoracic Surgeons
- Associate Editor, Frontiers in Surgery
- Mayo Clinic International Committee Chair, Mayo Clinic-United Kingdom/Western Europe Regional Demand Generation Team
Research
Dr. Cassivi’s research looks into the use of low-dose spiral CT scans for the detection of asymptomatic and early-stage lung cancer and surgical quality and outcomes as well as tissue and organ regeneration.[2]
He is involved in numerous clinical trials being conducted at Mayo Clinic with the collaboration of the American College of Surgeons Oncology Group and other major cancer collaborative study groups and is investigating the optimal surgical and post-operative treatment of early- and late-stage lung cancer.[2]
His most recent publications include:[3]
Sublobar Resection, Stereotactic Body Radiation Therapy, and Percutaneous Ablation Provide Comparable Outcomes for Lung Metastasis-Directed Therapy. Gits HC, Khosravi Flanigan MA, Kapplinger JD, Reisenauer JS, Eiken PW, Breen WG, Vu LH, Welch BT, Harmsen WS, Day CN, Olivier KR, Park SS, Garces YI, Hallemeier CL, Merrell KW, Ashman JB, Schild SE, Grams MP, Lucido JJ, Shen KR, Cassivi SD, Wigle D, Nichols FC, Blackmon S, Tapias LF, Callstrom MR, Owen D.Chest. 2023 Dec 14:S0012-3692(23)05853-1. doi: 10.1016/j.chest.2023.12.013. Online ahead of print.PMID: 38103730
Esophagectomy Enhanced Recovery After Surgery Initiative Results in Improved Outcomes. Sims CR 3rd, Abou Chaar MK, Kerfeld MH, Cassivi SD, Hofer RE, Nichols FC, Reisenauer J, Saddoughi SS, Shen KR, Stewart TM, Tapias LF, Wigle DA, Blackmon SH.Ann Thorac Surg. 2023 Dec 2:S0003-4975(23)01220-1. doi: 10.1016/j.athoracsur.2023.10.032. Online ahead of print.PMID: 38043851
Spontaneous middle lobe torsion: An institutional case series. Donato BB, Sewell M, Al Harakeh H, Sen A, Patel BM, Morgan P, Mathur AK, Moss AA, Hewitt WR, Campany ME, Dulohery Scrondin MM, Cassivi SD, Gajic O, D’Cunha J.JTCVS Tech. 2023 May 6;20:176-181. doi: 10.1016/j.xjtc.2023.04.006. eCollection 2023 Aug.PMID: 37555057
Determinants of Long-term Survival Decades After Esophagectomy for Esophageal Cancer. Abou Chaar MK, Godin A, Harmsen WS, Wzientek C, Saddoughi SA, Hallemeier CL, Cassivi SD, Nichols FC, Reisenauer JS, Shen KR, Tapias LF, Wigle DA, Blackmon SH.Ann Thorac Surg. 2023 Nov;116(5):1036-1044. doi: 10.1016/j.athoracsur.2023.05.033. Epub 2023 Jun 22.PMID: 37353102
Impact of FDG PET Standardized Uptake Value in Resected Clinical Stage IA Non-Small Cell Lung Cancer. Tapias LF, Shen R, Cassivi SD, Reisenauer JS, Lunn BW, Lechtenberg BJ, Nichols FC, Wigle DA, Blackmon SH.Ann Thorac Surg. 2023 Apr 19:S0003-4975(23)00394-6. doi: 10.1016/j.athoracsur.2023.04.013. Online ahead of print.PMID: 37080373
